Here are six articles Becker's Hospital Review published in the last week, featuring a look at the Drug Enforcement Agency's mandate to decrease opioid production by 20 percent in 2018 and CVS Health's "real-time benefits" tool to boost drug price transparency.
1. Shuttered Tennessee hospital scraps plan to sell medical equipment to pay for employees' wages
The permanently closed Copperhill, Tenn.-based Copper Basin Medical Center canceled a planned two-day sale of its supplies and medical equipment. Officials had reportedly planned to use proceeds from the sale to pay past-due wages for the hospital's former employees.
2. Sun Pharma recalls diabetes drug due to fungal contamination
Sun Pharmaceutical Industries recalled two lots of the diabetes drug Riomet over contamination issues.
3. WHO: 1 in 10 drugs in poor countries are counterfeit, ineffective
About 10 percent of medical products in the world's poorest countries are either counterfeits or do not meet quality requirements, according to research from the World Health Organization.
4. CVS launches 'real-time benefits' tool to increase price transparency
CVS Health's pharmacy benefits manager, CVS Caremark, launched its "real-time benefits" tool to increase price transparency across all points of care.
5. DEA mandates 20% reduction in opioid manufacturing for 2018
The DEA issued an order Nov. 8 finalizing an August proposal to mandate a 20 percent decrease in the production of certain opioid medications for 2018.
6. Hartford HealthCare claims over 900 vaccines may be ineffective
Hartford (Conn.) HealthCare is recommending 953 patients receive second vaccinations or tuberculosis tests because initial vaccines and tests may be ineffective.